ITERUM THERAPEUTICS PLC (ITRMF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 57 77 sessions, April 1, 2026 to July 30, 2026
- Largest daily move
- +200% close of April 30, 2026
- 1-month change
- -99.8% closing prices, June 30, 2026 to July 30, 2026
Company Description
ITERUM THERAPEUTICS PLC (OTC: ITRMF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $532.0.
ITRMF has declined 99.8% over the past month. The last closing price was $0.0001.
For FY2024, ITERUM THERAPEUTICS PLC reported net income of -$24.8M and diluted earnings per share of -$1.26.
This page collects what Stock Titan holds for ITRMF, including price data, SEC filings, financial highlights, and short interest trends.
Stock Performance
ITERUM THERAPEUTICS PLC (ITRMF) closed at $0.0001 on July 30, 2026. Over the past month, the price has lost 99.8%.
ITRMF Metrics & Rankings
Price returns through July 30, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
ITERUM THERAPEUTICS PLC has filed 1 recent SEC filing, including 1 Form 25-NSE. The most recent filing was submitted on June 23, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ITRMF SEC filings →
Financial Highlights
operating income reached -$18.7M, and net income was -$24.8M. Diluted earnings per share stood at -$1.26. The company generated -$26.8M in operating cash flow. The current ratio was 1.41, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in ITERUM THERAPEUTICS PLC (ITRMF) currently stands at 1.7 million shares, representing 3.9% of the shares outstanding.
Days to Cover History
Days to cover for ITERUM THERAPEUTICS PLC (ITRMF) currently stands at 1000.0 days. The ratio is the reported short interest divided by the average daily trading volume. Since April 2026, the figure has increased by 99899%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
ITRMF Company Profile & Sector Positioning
ITERUM THERAPEUTICS PLC (ITRMF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.